Related by context. All words. (Click for frequent words.) 75 CVD mortality 71 nonfatal MI 70 coronary heart 69 CHD mortality 69 myocardial infarction MI 69 cardiovascular morbidity 68 cardiovascular disease CVD 68 thrombotic events 68 microalbuminuria 67 HbA1c levels 67 nonfasting triglycerides 67 serum vitamin D 67 nonfatal stroke 67 subclinical atherosclerosis 67 tHcy 67 serum uric acid 67 cardiovascular disease 67 HbA 1c 67 subclinical hypothyroidism 67 myocardial infarction 66 magnesium intake 66 myocardial infarction stroke 66 statin therapy 66 albuminuria 66 subclinical hyperthyroidism 66 coronary disease 66 highest quintile 66 nonfasting triglyceride levels 66 folate intake 66 serum cholesterol 66 cerebral infarction 65 reinfarction 65 coronary artery disease 65 colorectal adenomas 65 postmenopausal breast cancer 65 metabolic syndrome 65 left ventricular hypertrophy 65 MetS 65 cardiovascular hospitalization 65 serum creatinine levels 65 colorectal neoplasia 65 lipid levels 65 elevated LDL cholesterol 65 microvascular complications 65 fasting glucose levels 65 serum calcium 64 venous thrombosis 64 macrovascular 64 carotid IMT 64 haemorrhagic stroke 64 cardiovascular hospitalizations 64 colorectal cancer incidence 64 HF hospitalization 64 ATACAND 64 elevated homocysteine 64 serum phosphate 64 vertebral fracture 64 hydroxyvitamin D levels 64 anovulatory infertility 64 elevated CRP 64 dietary calcium intake 64 postoperative mortality 64 nonvertebral fractures 64 recurrent VTE 64 left ventricular dysfunction 64 glycated hemoglobin levels 64 homocysteine levels 64 atherothrombotic disease 64 proteinuria 64 VTE 64 renal dysfunction 63 β blockers 63 intima media thickness 63 nondiabetic patients 63 ischemic stroke 63 serum triglycerides 63 spontaneous preterm delivery 63 CHD 63 macrovascular events 63 atherogenic dyslipidemia 63 venous thromboembolism 63 arterial stiffness 63 elevated triglyceride levels 63 multivariate adjustment 63 dysglycemia 63 cardiorespiratory fitness 63 polyp recurrence 63 hsCRP 63 triglyceride levels 63 colorectal adenoma 63 fatal myocardial infarction 63 carotid stenosis 63 NAFLD 63 transferrin saturation 63 hip BMD 63 HDL C 63 Lp PLA2 63 LV dysfunction 63 cardiac dysfunction 62 elevated hsCRP 62 coronary artery calcification 62 thromboembolic 62 glycosylated hemoglobin HbA1c 62 macrovascular disease 62 recurrent ischemia 62 hypertensive patients 62 lipid abnormalities 62 noncardiovascular mortality 62 systolic BP 62 myocardial infarctions 62 modifiable risk 62 thyrotropin levels 62 PSADT 62 nonfatal myocardial infarction 62 fatal IHD 62 highest tertile 62 Erythropoietic therapies may 62 cerebrovascular events 62 systolic hypertension 62 arterial thromboembolic events 62 platelet reactivity 62 de ath 62 nonfatal heart 62 preserved ejection fraction 62 folate deficiency 62 eplerenone 62 triglyceride concentrations 62 depressive symptoms 62 C reactive protein 62 albumin excretion 62 rs# [002] 62 systolic dysfunction 62 thromboembolism 62 LDL cholesterol levels 62 baseline HbA1c 62 non fasting triglycerides 62 abdominal obesity 62 dietary fiber intake 62 lipid lowering therapy 61 coronary calcification 61 CHD CVD 61 thromboembolic events 61 cystatin C 61 HOMA IR 61 diabetes mellitus 61 calcium supplementation 61 sudden cardiac death 61 postoperative AF 61 eGFR 61 symptomatic VTE 61 hippocampal volume 61 tirofiban 61 MMSE scores 61 thiazide diuretics 61 abdominal adiposity 61 contralateral breast cancer 61 recurrent venous thromboembolism 61 gallstone disease 61 nondiabetic 61 inflammatory markers 61 lowest tertile 61 beta blocker therapy 61 metabolic abnormalities 61 carotid atherosclerosis 61 TT genotype 61 HbA1C levels 61 impaired fasting glucose 61 serum urate levels 61 hs CRP 61 binary restenosis 61 microbleeds 61 preterm delivery 61 HDL cholesterol 61 glycemia 61 elevated fasting glucose 61 elevated triglycerides 61 troponin T 61 fasting insulin 61 hyperkalemia 61 periprocedural MI 61 hyperglycaemia 61 comorbidity 61 antihypertensive therapy 61 hypertensives 61 heart disease 61 normotensive 61 pCR 61 myocardial ischemia 61 severe hypoglycemia 61 serum potassium 61 confidence interval #.#-#.# 61 severe periodontitis 61 T2DM 61 acrylamide intake 61 elevated uric acid 60 ipsilateral stroke 60 serum GGT 60 homocysteine concentrations 60 glycated hemoglobin HbA1c 60 glomerular filtration rate 60 periprocedural 60 definite stent thrombosis 60 LVEF 60 glycated hemoglobin 60 ischemic cardiomyopathy 60 plasma triglycerides 60 repeat revascularization 60 autonomic dysfunction 60 intracerebral hemorrhage 60 ischemic strokes 60 cardio vascular disease 60 #mg/dL [001] 60 acute coronary syndrome 60 serum PTH 60 hsCRP levels 60 left ventricular systolic 60 nmol L 60 mL/min/#.# m 2 60 prostate cancer CaP 60 adiponectin concentrations 60 pre menopausal 60 albumin excretion rate 60 dyslipidaemia 60 diastolic BP 60 nonsignificant 60 hyperhomocysteinemia 60 extrapyramidal symptoms 60 white matter hyperintensities 60 KIF6 carriers 60 serum calcium levels 60 PSA velocity 60 plasma homocysteine 60 valsartan 60 NHANES III 60 elevated ALT 60 inverse association 60 plasma homocysteine levels 60 LVSD 60 postmenopausal women 60 inflammatory biomarkers 60 adiponectin levels 60 testosterone supplementation 60 dietary folate intake 60 advanced adenoma 60 serum lipid levels 60 ADHF 60 nonfatal myocardial infarction MI 60 candesartan 60 myocardial infarctions MIs 60 adiposity 60 hypertension 60 cerebral microbleeds 60 LDL C 60 serum urate 60 rosuvastatin 60 plasma folate 60 dietary sodium 60 cognitive decline 60 distal colon cancer 60 serum parathyroid hormone 59 density lipoprotein cholesterol 59 hemoglobin A1c HbA1c 59 arterial thickening 59 CC genotype 59 fructose intake 59 carotid plaque 59 fasting glucose 59 adenoma 59 vitamin D insufficiency 59 nondiabetics 59 POAG 59 TEAEs 59 hemoglobin A1c levels 59 Prehypertension 59 serum folate 59 neutrophil counts 59 serum PSA 59 Calcium intake 59 Leitzmann 59 acute coronary 59 uric acid levels 59 statins 59 hypercholesterolaemia 59 asymptomatic carotid stenosis 59 serum folate concentrations 59 carotid plaques 59 thromboembolic complications 59 calcium intake 59 Hb A1C 59 recurrent stroke 59 perinatal mortality 59 esophageal adenocarcinoma 59 atherothrombotic events 59 serum testosterone 59 lignan intake 59 serum selenium 59 recurrent myocardial infarction 59 virologic response 59 endothelial dysfunction 59 cerebrovascular disease 59 disease CHD 59 rs# [003] 59 atherosclerotic vascular disease 59 paclitaxel eluting stents 59 serum estradiol 59 pioglitazone 59 CK MB 59 upper gastrointestinal bleeding 59 abnormal glucose tolerance 59 intact parathyroid hormone 59 nonadherence 59 clopidogrel 59 Subgroup analyzes 59 dietary folate 59 density lipoprotein HDL cholesterol 59 A1c levels 59 platelet inhibition 59 dyslipidemia 59 serum sodium 59 premenopausal breast cancer 59 urinary oxalate 59 serum sodium levels 59 microvascular disease 59 vitamin D supplementation 59 elevated depressive symptoms 59 advanced adenomas 59 % CI #.#-#.# [006] 59 atherosclerosis 59 urate levels 59 trans fat intake 59 cardiovascular disease hypertension 59 VLDL cholesterol 59 osteoporotic fracture 59 morbidity mortality 59 urinary albumin excretion 59 lipid lowering medications 59 hypercholesterolemia 59 comorbidities 59 vitamin D intake 59 pulmonary exacerbations 59 visceral adiposity 59 perindopril 59 #.#/#.# mmHg [001] 59 iodine intake 59 Fonarow 59 HIV HCV coinfected 59 thrombotic complications 59 androgen deficiency 59 saturated fat intake 59 protein excretion 58 premenopausal 58 mg dL 58 perioperative mortality 58 systemic embolism 58 tiotropium 58 proliferative diabetic retinopathy 58 #OHD levels 58 intracerebral haemorrhage 58 alanine aminotransferase ALT 58 statin 58 aortic stiffness 58 XIENCE V demonstrated 58 insulin resistance 58 RBP4 levels 58 atherothrombosis 58 mIU L 58 ventricular tachyarrhythmia 58 lowering LDL cholesterol 58 cardioembolic stroke 58 ejection fractions 58 NYHA class 58 unstable angina 58 symptomatic intracranial 58 hypertension diabetes mellitus 58 tertile 58 ischemic cardiovascular 58 abnormal lipids 58 hydroxyvitamin D 58 unstable angina pectoris 58 SCr 58 macroalbuminuria 58 premenopausal women 58 HbA 1c levels 58 thyroid hormone levels 58 coronary artery calcium 58 LDL cholesterol concentrations 58 postmenopausal 58 biochemical recurrence 58 triglyceride concentration 58 contrast induced nephropathy 58 Ascherio 58 postoperative atrial fibrillation 58 nondrinkers 58 HYVET 58 cotinine levels 58 lipid lowering drugs 58 serum leptin 58 dietary intake 58 prevalences 58 antioxidant supplementation 58 eosinophil count 58 BRCA1 mutations 58 atherosclerotic cardiovascular disease 58 endometrial cancer 58 carotid intima media 58 #mmHg [001] 58 endometrial hyperplasia 58 LDL cholesterol 58 left ventricular ejection 58 osteoporotic fractures 58 serum creatinine 58 perimenopausal women 58 cholesterol LDL C 58 APOE e4 58 hyperlipidaemia 58 serum glucose 58 creatinine levels 58 vasomotor symptoms 58 isolated systolic hypertension 58 dietary intakes 58 myocardial uptake 58 tertiles 58 estrogen progestin therapy 58 Winkelmayer 58 silent myocardial ischemia 58 infarct size 58 selenium intake 58 NYHA Class II 58 CrCl 58 ABCB1 58 urinary calcium 58 fragility fractures 58 nephropathy 58 tolvaptan 58 mm Hg systolic 58 prospective cohort 58 noncarriers 58 liver transplant recipients 58 HbA1C 58 mammographic density 58 urinary excretion 58 serum IGF 58 gestational hypertension 58 cardiometabolic risk 58 coronary revascularization 58 haemorrhagic strokes 57 breast cancer recurrence 57 nocturnal hypoglycemia 57 antihypertensive medications 57 serum phosphorus 57 alanine aminotransferase 57 triacylglycerol concentrations 57 telomere lengths 57 familial clustering 57 non valvular atrial 57 IPAH 57 nonalcoholic steatohepatitis NASH 57 lipid profiles 57 creatinine ratio 57 metabolic parameters 57 glucose intolerance 57 HbA1c 57 aldosterone 57 nonmelanoma skin cancer 57 gene polymorphism 57 cardiovascular calcification 57 virologic failure 57 ivabradine 57 cognitive impairment 57 rs# [001] 57 atherosclerotic disease 57 renal insufficiency 57 morphometric vertebral fractures 57 hypoglycemic events 57 platelet activation 57 mixed hyperlipidemia 57 neurodevelopmental outcome 57 cardiovascular 57 % CI #.#-#.# [002] 57 BRCA mutation carriers 57 serum CRP 57 chlamydial infection 57 flavonoid intake 57 spontaneous preterm birth 57 lobular breast cancer 57 tibolone 57 neurodevelopmental impairment 57 carotid artery narrowing 57 serum concentrations 57 BRCA2 mutations 57 nonselective NSAIDs 57 glycosylated hemoglobin 57 Epidemiologic studies 57 noncardiac 57 folic acid intake 57 MACCE 57 SHBG levels 57 A1C levels 57 impaired glucose tolerance 57 hyperglycemia 57 lipoprotein levels 57 intensive statin therapy 57 COPD exacerbations 57 abnormal lipid 57 multivariable adjusted 57 atherosclerotic progression 57 uncontrolled hypertension 57 T2D 57 lumbar spine BMD 57 onset atrial fibrillation 57 lipid lowering agents 57 postoperative complication 57 ventricular mass 57 estrogen receptor negative 57 univariate analyzes 57 Exacerbations 57 urinary tract symptoms LUTS 57 alcoholic fatty liver 57 hip fractures 57 aminotransferases 57 undergone radical prostatectomy 57 lung function 57 hyperlipidemia 57 ischemic heart 57 MGUS 57 hypoglycemic episodes 57 selenium supplementation 57 systolic blood pressure 57 #.#ng/ml 57 hip fracture 57 alcoholic cirrhosis 57 gestational diabetes mellitus 57 hormone therapy estrogen 57 serum homocysteine 57 fasting plasma glucose FPG 57 sUA 57 postoperative complications 57 myocardial fibrosis 57 impaired glucose metabolism 57 acute myocardial infarction AMI 57 VT VF 57 RBP4 57 parkinsonism 57 lipid parameters 57 noncardiovascular 57 dose clopidogrel 57 salmeterol HFA MDI 57 acute myocardial infarctions 57 prognostic significance 57 pulmonary capillary wedge 57 QTc interval 57 LUTS 57 baseline serum creatinine 57 BRCA2 mutation carriers 57 NPH insulin 57 sustained virological response 57 c reactive protein 57 serum BDNF 57 estimated glomerular filtration 57 transaminase levels 57 adenoma recurrence 57 nocturnal hypoglycaemia 57 rimonabant #mg 57 colorectal cancer 57 diastolic blood pressures 57 statistically nonsignificant 57 hemoglobin A1c 57 antiplatelet therapy 57 antigen PSA 57 beta carotene supplementation 57 BMI z 57 venous thromboembolic disease 57 Stent thrombosis 57 annualized relapse 57 NT proBNP 57 NATRECOR ® 57 Framingham Offspring Study 57 reach statistical significance 57 neurocognitive function 57 echocardiographic parameters 57 potentially modifiable 57 mmol L 57 HDL2 57 benign breast 57 plasma urate 57 fasting plasma glucose 57 polycystic ovary syndrome PCOS 57 hemoglobin concentrations 57 hypertensive 57 perioperative complications 57 confounders 56 atheroma volume 56 coronary atherosclerosis 56 prospectively defined 56 Cognitive impairment 56 statistically significant correlations 56 femoral neck BMD 56 T1DM 56 index BMI 56 abnormal lipid levels 56 nmol l 56 venous thromboembolic events 56 prostate carcinogenesis 56 vascular inflammation 56 silent ischemia 56 CLA supplementation 56 thyrotropin 56 disease progression 56 TZDs 56 mmHg diastolic 56 paricalcitol 56 glomerular filtration 56 phytoestrogen intake 56 diastolic heart 56 non aspirin NSAIDs 56 fluvastatin 56 brain atrophy 56 severe exacerbations 56 symptomatic intracerebral hemorrhage 56 cirrhotic patients 56 Pischon 56 hemoglobin concentration 56 dose aspirin 56 #.#mmol L [002] 56 urinary albumin 56 serum testosterone levels 56 irbesartan 56 thyroid dysfunction 56 bronchopulmonary dysplasia 56 shorter telomere length 56 severe hypoglycemic 56 Homocysteine 56 resistant hypertension 56 neonatal morbidity 56 bilateral oophorectomy 56 prolactin levels 56 benazepril 56 adiponectin 56 chlorthalidone 56 NAT2 56 metabolic syndrome MetS 56 P = .# 56 vascular disease 56 recurrent DVT 56 SHBG 56 asthma exacerbations 56 PSA nadir 56 familial AF 56 acute coronary syndromes 56 severe hypoglycaemia 56 confidence intervals CIs 56 ticagrelor 56 dose statin therapy 56 blood lipids 56 leukocyte count 56 vegetable intake 56 residual confounding 56 atherothrombotic 56 angina myocardial infarction 56 urinary symptoms 56 URTI 56 intracranial hemorrhage ICH 56 CI #.#-#.# [002] 56 endometrial carcinoma 56 telmisartan 56 genetic polymorphisms 56 pg ml 56 HNSCC 56 hemorrhagic strokes 56 umol L 56 cTnT 56 preoperative PSA 56 Helicobacter pylori infection 56 fetuin 56 events MACE 56 serum phosphate levels 56 vascular dysfunction 56 QTc intervals 56 LDL lowering 56 Cooper DeHoff 56 aged ≥ 56 loop diuretics 56 inversely associated 56 LV ejection fraction 56 hypercalciuria 56 BRCA mutations 56 NSTE ACS 56 exacerbations 56 tHcy concentrations 56 aminotransferase ALT 56 renal impairment 56 atypical hyperplasia 56 salivary flow 56 asymptomatic PAD 56 thiazide diuretic 56 acute myocardial infarction 56 lobular cancer 56 nonobese 56 Epidemiological studies 56 hemorrhagic complications 56 folate supplementation 56 NNRTI resistance 56 psychiatric morbidity 56 retinal vein occlusion 56 aldosterone antagonist 56 Coronary artery calcification 56 nonischemic 56 isoflavone intake 56 univariate analysis 56 UACR 56 venous thromboembolism VTE 56 myeloperoxidase 56 decompensated heart failure 56 nonvertebral fracture 56 hepatic steatosis 56 candesartan cilexetil 56 subtrochanteric 56 patients undergoing CABG 56 onset diabetes mellitus 56 hippocampal atrophy 56 mortality 56 Vitamin D supplementation 56 serum triglyceride levels 56 thromboembolic disease 56 plasma lipids 56 Lp PLA 2 56 AAT deficiency 56 Depressive symptoms 56 serum retinol 56 NATRECOR R 56 comorbid conditions 56 AUDs 56 undergoing coronary angiography 56 prolonged QT interval 56 lowering homocysteine 56 metformin monotherapy 56 Bibbins Domingo 56 waist circumference 56 brain shrinkage 56 serum ferritin 56 nondepressed 56 mg BID dose 56 locoregional recurrence 56 PRADAXA #mg 56 inflammatory rheumatic 56 ALLHAT 56 serum lipids 56 postmenopausal hormone 56 pressure natriuresis 56 dietary patterns 56 cardiac biomarkers 56 folate concentrations 56 familial aggregation 56 XIENCE V PROMUS Stent 56 hydroxyvitamin D concentrations 56 multivariate Cox 56 angiotensin receptor blockers ARBs 56 Kivipelto 56 ventricular arrhythmia 56 PM#.# exposure 56 dietary sodium intake 56 uncontrolled asthma 56 lowest quintile 56 neovascular AMD 56 target vessel revascularization 56 homocysteine 56 primary hypercholesterolemia 56 postoperative delirium 56 MDRD 56 dapagliflozin plus 56 antihypertensive drugs 56 insulin glargine 56 acute myocardial infarction MI 56 foveal thickness 55 psychiatric comorbidities 55 comorbid illnesses 55 airflow obstruction 55 hormone receptor negative 55 folic acid supplementation 55 INTERHEART 55 insulin resistance syndrome 55 PNH patients 55 fasting triglyceride levels 55 variceal bleeding 55 MMSE score 55 recurrent UTI 55 cTnT levels 55 hemodialysis patients 55 systolic 55 BRCA1 mutation carriers 55 DASH diet 55 % CI #.#-#.# [007] 55 carotid endarterectomy 55 ng dL 55 calcium intakes 55 CHD coronary 55 poorer prognosis 55 hyperinsulinemia 55 bezafibrate 55 renal artery stenosis 55 plasma renin activity 55 apolipoprotein B 55 lipid elevations 55 congenital malformations 55 hypercalcaemia 55 statistically significant 55 coronary revascularizations 55 stent thrombosis 55 ezetimibe simvastatin 55 rosiglitazone 55 bone resorption 55 NYHA functional class 55 cardiac toxicity 55 colorectal cancer CRC 55 oxycodone CR 55 INTERHEART study 55 hypercalcemia 55 metabolic disturbances 55 H. pylori infection 55 neurologic complications 55 poor metabolizers 55 systolic diastolic 55 glycemic load 55 HER2 expression 55 lumiracoxib 55 diabetes mellitus DM 55 estrogen deficiency 55 HMG CoA reductase inhibitors 55 severe psoriasis 55 carotid bruit 55 ovulatory infertility 55 stable angina 55 ticlopidine 55 mineral density 55 dysfunction LVSD 55 liver histology 55 ng mL 55 hereditary predisposition 55 MDRD equation 55 systolic blood pressures 55 Kaplan Meier analysis 55 postmenopausal hormone therapy 55 lifetime abstainers 55 caffeinated coffee 55 elevated LDL 55 Vitamin D insufficiency 55 preeclampsia 55 body fatness 55 elevated IOP 55 angina chest 55 apnea hypopnea index 55 antihypertensive medication 55 #mmHg [002] 55 penetrance 55 #.#mg/dL 55 oral antidiabetic drugs 55 infarctions 55 metformin 55 modifiable lifestyle 55 myocardial ischaemia 55 ductal cancer 55 Avandia Actos 55 NSTEMI 55 MADRS score 55 total cholesterol triglycerides 55 basal cell nevus syndrome 55 habitual snoring 55 invasive breast cancer 55 olmesartan 55 genetic variants associated 55 #.#mmol L [001] 55 angiotensin converting enzyme inhibitor 55 hyperparathyroidism 55 atherogenic lipids 55 co morbidities 55 overt nephropathy 55 steatosis 55 composite endpoint 55 RBC folate 55 resuscitated cardiac arrest 55 ximelagatran 55 hypogonadal 55 euthyroid 55 Proteinuria 55 undergoing coronary artery 55 prednisone prednisolone 55 ACE inhibitors 55 rs# [004] 55 nmol L. 55 obstructive CAD 55 rebleeding 55 Myocardial infarction 55 nephrotoxicity 55 SORT OUT III 55 gastric cardia 55 Triglyceride levels 55 CYP#C# [001] 55 urolithiasis 55 cardioprotective effects 55 vitamin D deficiency 55 dietary calcium 55 kidney dysfunction 55 hepatic cirrhosis 55 aminotransferase levels 55 shorter telomeres 55 Taxus Stent 55 blood glucose concentrations 55 coronary stenosis 55 valvular disease 55 depressive symptomatology 55 Homocysteine levels 55 deep venous thromboses 55 homozygotes 55 antigen PSA levels 55 nonmelanoma skin cancers 55 mcg dL 55 postprandial insulin 55 nicardipine 55 sporadic ALS 55 KIF6 gene variant 55 VTEs 55 vitamin D deficient 55 thyrotoxicosis 55 intracranial stenosis 55 observational studies 55 eptifibatide 55 parous women 55 CP CPPS 55 plasma lipid 55 prescribed statins 55 impaired cognition 55 VaD 55 hypovitaminosis D 55 cognitively normal 55 EDARBI 55 advanced neoplasia 55 ARCOXIA 55 conventional antipsychotics 55 salmeterol fluticasone propionate 55 TAXUS p value 55 renal function 55 tumor histology 55 angiotensin converting enzyme inhibitors 55 refractory ischemia 55 IDDM 55 residual platelet reactivity 55 incidence 55 primary aldosteronism 55 atypia 55 nonalcoholic steatohepatitis 55 sulphonylurea 55 open angle glaucoma 55 familial hypercholesterolemia 55 rosuvastatin #mg 55 lymphocytosis 55 μg dL 55 cytopenias 55 tamsulosin 55 recurrent atrial fibrillation 55 overt hepatic encephalopathy HE 55 VADT 55 proliferative retinopathy 55 allergic sensitization 55 distant metastases 55 specific antigen PSA 55 Events MACE 55 abciximab 55 urinary tract symptoms 55 baseline A1C 55 hemolysis 55 hyperphenylalaninemia HPA due 55 hypogonadal men 55 diastolic blood pressure 55 neurological abnormalities 55 ventricular remodeling 55 arterial calcification 55 preterm deliveries 55 coinfected patients 55 serum ALT 55 CMV infection 55 recurrent coronary 55 FEV1 55 adrenal function 54 androgen suppression 54 clinically meaningful reductions 54 serum cotinine levels 54 coronary blockages 54 arterial hypertension 54 bronchial hyperresponsiveness 54 postoperative pulmonary 54 apoC III 54 autoantibody levels 54 ruboxistaurin 54 obstructive coronary artery 54 rehospitalization 54 ng ml 54 meta analysis 54 dietary glycemic index 54 plasma glucose levels